ABX-IL8

N/A

Report date: 2022/11/25 17:42:16

Base Information

Drug NameABX-IL8
Drug Alias NameAnti-interleukin-8 monoclonal antibodyABX-IL8
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAngiogenesis inhibitorsInterleukin-8 inhibitors
TargetsInterleukin-8
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) LtdXenotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbgenix Incorporated
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveBronchitis, Chronic

Other Information

ATC CodeN/A
Related LinksN/A